By Lynette Mabote-Eyde and Mike Frick Too often, major scientific advancements against tuberculosis (TB) get lost on the long and winding road of policy translation into practice. TB preventive treatment (TPT) has faced decades of dislocation between progressive global World…
We’re thrilled to share the 2023 edition of TAGline, which explores some of the barriers that obstruct research from being effectively implemented to improve people’s health.
By Natalie Shure In the years since I developed drug-resistant tuberculosis (DR-TB) in 2010, the field has welcomed several scientific advances that would have fundamentally changed my experience of living with the disease. For one thing, my two- year treatment…
This year’s edition of TAGline commemorates TAG’s 30th anniversary, and these articles explore TAG’s work over the years: what we've accomplished, what we've learned, the continuing obstacles to progress, and what comes next.
By Lindsay McKenna, Mike Frick, and Mark Harrington At the 24th International AIDS Conference in Montreal this summer, TAG, Partners In Health (PIH), and Médecins Sans Frontières (MSF) launched the 1/4/6x24 Campaign to accelerate equitable global uptake of newly discovered…
By Cheriko A. Boone, Abraham Johnson, and Richard Jefferys In a 1989 article by Dr. Anthony Fauci, “AIDS — Challenges to Basic and Clinical Biomedical Research” — which preceded Treatment Action Group’s founding by just a few years — he…
By David Branigan, Joelle Dountio Ofimboudem, and Natalie Shure TAG was founded in 1992 with the aim of accelerating the availability of effective HIV treatments through science-based advocacy at every step of the research, development, and implementation process. These strategies…
By Dorrit Walsh and Mark Harrington Since 1992, Treatment Action Group has been advocating for those affected by and struggling with HIV. Since then, we’ve expanded our mission to include tuberculosis (TB) — the leading cause of death by infectious…
By Mike Frick and Mark Harrington The articles in this 30th anniversary issue of TAGline grapple with “pandemic equity,” an increasingly common catchphrase in global health. COVID-19 has shown that “equity,” like its cousins “justice,” “fairness,” and “equality,” is one…
Delivering on the Promise of Long-Acting Forumulations delves deep into the development of long-acting formulations for the treatment and prevention of infectious diseases like HIV, tuberculosis, hepatitis C, and malaria. Long-acting medications have become common for conditions such as osteoporosis and schizophrenia, and they're even used for birth control.